Kindex Pharmaceuticals, Inc.

Kindex Pharmaceuticals, Inc.

Kindex Pharmaceuticals, Inc.

Overview
Date Founded

2009

Headquarters

265 Franklin Street,Suite 1702,Boston, MA 02110

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Biotechnology
Medical Support Services
Hospitals & Patient Services
Holding Companies

Company Description

Kindex Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on discovering and developing of novel therapeutics for the treatment of metabolic. The company is headquartered in Boston, MA.

Executives & Employees

Chief Executive Officer

Operations Manager

Director

Advisor

Scientific Advisors

Scientific Advisors

Paths to Kindex Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Kindex Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Kindex Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Kindex Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Kindex Pharmaceuticals, Inc. raised money in a private placement transaction

Advisors & Consultants
Advisor

Co-Founder at Alnylam Pharmaceuticals, Inc.

Advisor

Co-Founder at Vividion Therapeutics, Inc.

Advisor

Chief Executive Officer & Director at Curza Global LLC

Investors
Details Hidden

Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies.The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software.In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services.Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services.Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kindex Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kindex Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Kindex Pharmaceuticals, Inc..